ロード中...
CD73: A potential biomarker for anti-PD-1 therapy
In our recent study, we show that tumoral CD73 expression limits the efficacy of anti-PD-1 therapy, and this is rescued by concomitant A(2A) blockade. Since CD73 is known to be overexpressed in several human cancers and A(2A) antagonists have undergone clinical trials for Parkinson's Disease, t...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4589050/ https://ncbi.nlm.nih.gov/pubmed/26451321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1046675 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|